Budget vs premium
Embody vs IVIM Health: Which Costs Less Over 12 Months? (2026)
Compare Embody and IVIM Health on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.6 and 7.2 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Both Embody and IVIM Health will get a GLP-1 prescription to your door without an in-person visit. The question is what the year after that first shipment looks like.
On the number that matters after the first month, they are not close: Embody runs $69/mo against $174/mo at IVIM Health — 2.5x more, every month, for the same drug class.
What follows is a like-for-like read of both programs: entry pricing, maintenance pricing, formulary, support model and the terms attached to each. Anything a provider declines to disclose is marked undisclosed rather than filled in.
The short answer
- Lowest 12-month cost
- Embody — $828 against $2,013 at IVIM Health, on each provider's own best published pricing.
- Most support for the money
- IVIM Health — No-obligation free consultation valued at $75.
- Tirzepatide access
- Embody — Tirzepatide at $119/mo; the other side publishes semaglutide only.
- Most support included
- IVIM Health — No-obligation free consultation valued at $75.
Embody and IVIM Health, side by side
Every figure below is the provider's own published number. The blank spaces are theirs, not ours.
| Embody | IVIM Health | |
|---|---|---|
| Advertised price | Semaglutide $69/mo (was $299), tirzepatide $119/mo | $99 first month, then $174/mo |
| Rate after promotions | $69/mo | $174/mo |
| Pricing structure | Published rate per medication | Membership fee plus the cost of medication |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| State coverage | Not published | Not published |
| How fast you start | Licensed provider review handled entirely online | Free consult, then clinician review |
| Membership fee | None | Yes, billed separately |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 11,250 | 36,958 |
| eRxDoctor score | 7.6/10 | 7.2/10 |
What you will have spent by month twelve
Trial data runs to 68 and 72 weeks; the pricing people compare runs to 30 days. So the table works in the timeframe treatment actually happens in.
| Embody | IVIM Health | |
|---|---|---|
| First month | $69 | $99 |
| Months 2 onward | $69/mo | $174/mo |
| 6-month total | $414 | $969 |
| 12-month total | $828 | $2,013 |
| Best published plan | No multi-month discount published | No multi-month discount published |
The twelve-month spread is $1,185. That is the number to hold IVIM Health against: it has to justify roughly $99 extra every month.
Price escalation to plan for: IVIM Health moves from $99 to $174, a 76% increase. Set a calendar reminder for the month it changes.
What the price difference actually buys
Before treating the cheaper option as the obvious one, it is worth naming what the more expensive one includes — at IVIM Health that is no-obligation free consultation valued at $75, plus home delivery.
Embody's answer is the lowest published semaglutide price on this list, with no lock-in. What it does not carry: a limited-time rate with few of the extras that higher-priced platforms bundle.
For a patient who has taken a GLP-1 before, knows how they titrate and needs a reliable monthly refill, the cheaper program is usually the correct one and the premium is a donation. For a first prescription, the calculus changes.
Embody: what you are buying
Semaglutide $69/mo (was $299), Tirzepatide $119/mo Against IVIM Health, that puts it in the position of the cheaper option.
The process is licensed provider review handled entirely online, then free shipping, 1-2 day delivery after approval. On money, expect published rate per medication — published upfront.
Behind the prescription sits 24/7 support for dosing and side-effect questions. Available medication: compounded semaglutide and compounded tirzepatide.
Embody pros
- Compounded tirzepatide available at $119/month
- Lowest entry price on this list at $69/month for compounded semaglutide
- No long-term commitment; cancel without penalty
- Free shipping with fast 1–2 day delivery after approval
Embody cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Fewer premium features (no integrated coaching or advanced monitoring) than higher-priced platforms
- Final pricing may vary based on dose and clinician recommendation
The cost of choosing this over IVIM Health: a limited-time rate with few of the extras that higher-priced platforms bundle.
IVIM Health in detail
Limited Offer: Free Month Membership – Use Code GIFT75 What it is really selling here is 4.9 stars on both Google and Trustpilot, which is rare dual third-party verification.
Getting started means free consult, then clinician review, after which home delivery. Pricing runs on a membership fee plus the cost of medication basis, published upfront.
On the clinical side, no-obligation free consultation valued at $75, prescribing compounded semaglutide.
IVIM Health pros
- Competitive ongoing pricing at $174/month after a $99 first month
- 4.9-star rating on both Google and Trustpilot, rare dual third-party verification
- No-obligation free consultation ($75 value) for new patients
- Free month membership with code GIFT75
IVIM Health cons
- Compounded medication only, no branded Ozempic or Wegovy
- Price rises from $99 first month to $174/month ongoing
- The 40% faster claim is a proprietary protocol claim, not an independent clinical finding
Against Embody specifically, the trade you are making: the GLP-1 ID protocol's 40% faster claim is the platform's own, not an independent finding.
Who should choose Embody, and who should choose IVIM Health
Choose Embody if:
- the level of clinical contact suits you: 24/7 support for dosing and side-effect questions
- what it leads on is worth paying for in your case: the lowest published semaglutide price on this list, with no lock-in
- delivery works the way you want it to: free shipping, 1-2 day delivery after approval
- you want to start on their timeline: licensed provider review handled entirely online
Choose IVIM Health if:
- the level of clinical contact suits you: no-obligation free consultation valued at $75
- the feature you would actually use: 4.9 stars on both Google and Trustpilot, which is rare dual third-party verification
- delivery works the way you want it to: home delivery
- you want to start on their timeline: free consult, then clinician review
What each one gives up
On price. Embody is the cheaper program at $69/mo against $174/mo. What Embody gives up for that is a limited-time rate with few of the extras that higher-priced platforms bundle; what IVIM Health charges for is 4.9 stars on both Google and Trustpilot, which is rare dual third-party verification.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On predictability. The pricing structures differ (published rate per medication versus membership fee plus the cost of medication), and structure, not headline rate, determines the twelve-month bill.
On access. Embody advertises licensed provider review handled entirely online and free shipping, 1-2 day delivery after approval; IVIM Health advertises free consult, then clinician review and home delivery. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
What the evidence actually says
The efficacy data people cite when comparing these platforms is not platform data. It comes from trials of the underlying medication, and it applies to both.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
The SELECT trial found semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes, per NEJM, SELECT.
Use it as the floor for the conversation with whichever prescriber you end up with, rather than as a reason to pick one platform over the other.
Embody vs IVIM Health: common questions
Which is cheaper to start, Embody or IVIM Health?
Embody, at $69 against $99. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which costs less over a year, Embody or IVIM Health?
Embody, at roughly $828 for twelve months against $2,013 at IVIM Health, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Is Embody cheaper than IVIM Health?
Yes, on the ongoing rate. Embody runs $69/mo once promotional pricing ends, against $174/mo at IVIM Health — a difference of 2.5x. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Does Embody or IVIM Health charge a membership fee?
IVIM Health runs a membership-plus-medication model, so the monthly total is the membership plus whatever the medication costs on your plan. Embody charges $69/mo with no separate membership. When comparing the two, price the membership model at your expected maintenance dose rather than at the introductory rate.
Does Embody or IVIM Health offer tirzepatide?
Embody does, at $119/mo. IVIM Health publishes compounded semaglutide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
Do Embody and IVIM Health prescribe the same medication?
Both dispense compounded GLP-1 preparations. Embody lists compounded semaglutide and compounded tirzepatide and IVIM Health lists compounded semaglutide, so the molecules overlap even where the formulary does not match exactly.
Is Embody or IVIM Health better for a first GLP-1 prescription?
For a first prescription, weight support over price. IVIM Health offers more contact (no-obligation free consultation valued at $75), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
The verdict
Embody is the cheaper year by $1,185, and for a straightforward course of treatment that settles it.
IVIM Health earns the difference in one situation: when 4.9 stars on both Google and Trustpilot, which is rare dual third-party verification is something you will genuinely use. If you cannot say that out loud, take the cheaper program.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- Embody vs He & She MDBudget vs premium
- Embody vs MaximusBudget vs premium
- Directmeds vs IVIM HealthPublished price vs quote-only
- Enhance MD vs IVIM HealthBudget vs premium
- Mochi Health vs TMatesBudget vs premium
- LIV Body vs MaximusBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Embody or IVIM Health, and does not sell treatment. Read our ranking methodology.